YAP1 and polycystic ovary syndrome: Therefore, our study sought to examine the nuclear-cytoplasmic distribution of YAP1 in KGN cells treated with n-3 PUFA compared with the control group, which revealed a marked reduction in the number of YAP1 nuclei in the n-3 PUFA group as opposed to the PCOS group, as displayed in Figure 5b.